Literature DB >> 7418184

Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.

R L Rinkenberger, E N Prystowsky, J J Heger, P J Troup, W M Jackman, D P Zipes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7418184     DOI： 10.1161/01.cir.62.5.996

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.

Authors:  D N John; S Fort; M J Lewis; D K Luscombe
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

2.  Nonlinear-dynamical arrhythmia control in humans.

Authors:  D J Christini; K M Stein; S M Markowitz; S Mittal; D J Slotwiner; M A Scheiner; S Iwai; B B Lerman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Calcium channel blockers and cardiovascular therapeutics.

Authors:  B N Singh
Journal:  West J Med       Date:  1982-07

4.  Intestinal pseudo-obstruction related to using verapamil.

Authors:  H S Schultz; B Vernon
Journal:  West J Med       Date:  1989-11

Review 5.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

6.  Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter.

Authors:  S Fort; M J Lewis; D K Luscombe; D N John
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  The impact of therapeutic reference pricing on innovation in cardiovascular medicine.

Authors:  Desmond Sheridan; Jim Attridge
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

Review 8.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

9.  Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.

Authors:  C-J A Lindholm; O Fredholm; S-J Möller; N Edvardsson; T Kronvall; T Pettersson; V Firsovaite; A Roijer; C J Meurling; P G Platonov; S B Olsson
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.

Authors:  K Hirao; K Okishige; F Suzuki; K Hiejima
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.